Kumamoto, Japan

Kanako Niimori

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Kumamoto University, Tokyo Institute of Technology. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kanako Niimori. Retrieved from https://idiyas.com/inventor/kanako-niimori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kanako Niimori: Innovator in Cancer Treatment

Introduction

Kanako Niimori is a prominent inventor based in Kumamoto, Japan. She has made significant contributions to the field of medicine, particularly in the development of treatments for cancer. Her innovative approach focuses on understanding the role of stem cell control factors in cancer differentiation.

Latest Patents

Niimori holds a patent for a medicine and method for treating cancer. This invention aims to reveal the role of a stem cell control factor, specifically Matrin-3, in cancers that exhibit neural differentiation, including small cell lung cancer. The patent outlines a method to suppress the proliferative nature of cancer by disrupting the balance of stem cell control factors that differ from those in normal cells.

Career Highlights

Throughout her career, Kanako Niimori has worked at prestigious institutions, including Kumamoto University and the Tokyo Institute of Technology. Her research has focused on the mechanisms of cancer stem cells and their implications for treatment strategies.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Kanako Niimori's work in cancer treatment exemplifies the intersection of innovative research and practical application in medicine. Her contributions are paving the way for new therapeutic approaches to combat cancer effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…